Evidence map›Paper›PMID 38610815›Full record

ArticleJournal of clinical medicine2024

Elevated Prostaglandin E

Silvia Gartner, Jordi Roca-Ferrer, Paula Fernandez-Alvarez, Isabel Lima, Sandra Rovira-Amigo, Elena García-Arumi, Eduardo F Tizzano, César Picado

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 0 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Silvia GartnerUnidad de Neumología Pediátrica y Fibrosis Quística, Hospital Vall d'Hebrón, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.ORCID 0000-0002-8190-5092
Jordi Roca-FerrerHospital Clinic, Universitat de Barcelona, 08036 Barcelona, Spain.
Paula Fernandez-AlvarezÁrea de Genética Clínica y Molecular, Hospital Vall d'Hebrón, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.ORCID 0000-0003-2695-3531
Isabel LimaUnidad de Neumología Pediátrica y Fibrosis Quística, Hospital Vall d'Hebrón, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
Sandra Rovira-AmigoUnidad de Neumología Pediátrica y Fibrosis Quística, Hospital Vall d'Hebrón, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
Elena García-ArumiÁrea de Genética Clínica y Molecular, Hospital Vall d'Hebrón, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
Eduardo F TizzanoÁrea de Genética Clínica y Molecular, Hospital Vall d'Hebrón, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
César PicadoHospital Clinic, Universitat de Barcelona, 08036 Barcelona, Spain.ORCID 0000-0001-7400-4993
Universitat Autònoma de Barcelona · ESCentro de Investigación Biomédica en Red de Enfermedades Respiratorias · ES

Funding

Fundació Catalana de Pneumolgia (FUCAP) 8/2018
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

air trappingbronchiectasisCF transmembrane conductance regulator genecystic fibrosispolymorphismsprostaglandin D2prostaglandin E2tetranor-PGDMtetranor-PGEM

Identifiers

PMID38610815
PMCPMC11012863
OpenAlexW4393540751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.